European Pharmaceutical Review

JULY 4, 2023

As drug development professionals know, global health crises like the COVID-19 pandemic provide the public with valuable insights into how clinical research and regulatory processes work. What are the main challenges quality assurance and compliance professionals face during the drug development and review process?

Drug Development 98

Drug Development Communication Dosage Chemotherapy 98

Pharmaceutical Technology

FEBRUARY 23, 2023

Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).

Drug Development 98

Drug Development Compounding Dosage Packaging 98

Pharmaceutical Technology

JUNE 15, 2023

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.

Drug Development 52

Drug Development Adverse Reactions Compounding Dosage 52

Pharmacy Is Right For Me

APRIL 4, 2023

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! It also improves care coordination and eliminates communication gaps. It involves the training of community paramedics in performing some aspects of medication reconciliation.

Hospitals 130

Hospitals Communication Medical Records Dosage 130

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. Nowadays, you have drugs against cancer which have a very high impact even at a very low dosage.”.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 22, 2023

Nicklas Westerholm, the CEO and president of orphan drug developer Egetis Therapeutics, says disease awareness amongst paediatric neurologists and endocrinologists is low for MCT8 deficiency. The FDA will weigh the concerns and benefits of this drug before its PDUFA date in October. compared to 38.5% on placebo.

Communication 126

Communication Dosage Drug Development 126

Viseven

AUGUST 15, 2024

The traditional model of drug development and healthcare delivery is undergoing a seismic shift, with patient engagement emerging as a critical factor in achieving better health outcomes and driving innovation. This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

European Pharmaceutical Review

JUNE 24, 2022

But what are the key potential changes and how could they impact drug developers and manufacturers? He noted that within the proposals, there is likely to be a differentiation in incentives for drug development in the orphan and unmet medical need areas. Key areas of potential legislative change. Future outlook.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

Pharmaceutical Technology

JULY 18, 2022

Raw ingredients themselves may also behave differently at this stage, says Ingrid Coyle, MEDELPHARM’s director corporate business development and communication. Compaction simulation is arguably the most important when dealing with oral solid dosage forms. There is a risk for variation between batches.”.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage Communication 52

Pharmaceutical Technology

FEBRUARY 21, 2023

For Skyepharma, a CDMO specialising in oral solid dosage forms, notable reductions in costly product waste was one advantage. Versatility Finding a versatile R&D tablet press is key for flexible drug development. Testing a formulation on MEDELPHARM’s single-punch tablet press required just 0.9kg of powder.

Communication 52

Communication Drug Development Dosage 52

ID Stewardship

JUNE 6, 2023

Patient Education and Adherence : AI chatbots or virtual assistants can be developed to provide patients with on-demand information about their medications, dosages, potential side effects, and adherence strategies. AI can assist in language translation, improving communication with non-native speakers.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling Hospitals Medication Dispensing 52

Pharmaceutical Technology

APRIL 12, 2023

Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. The nominal load capacity is 130 kg, which allows for large production batches of up to 200 litres with flow monitoring. Please check your email to download the Whitepaper.

Controlled Substances 52

Controlled Substances Dosage Pharmaceutical Companies Communication 52

PharmaTech

JUNE 12, 2025

While FDA warning letters generally do not authorize the execution of any definitive actions by the agency, they do specify actions that may be taken if FDA’s suggestions and requests are not adhered to, usually to be communicated by a company within a window of 15 business days of receipt of FDA’s letter.

Dosage 59

Dosage Drug Development Labelling Compounding 59